Nicotinamide Adenine Dinucleotide 1g & Tirzepatide's Successor : A United Kingdom Report
The emerging interest in NAD+ supplementation, particularly at a substantial dosage of 1g , continues to rise within the United Kingdom pharmaceutical community. Concurrently, attention is directed toward Retatrutide, a novel GLP-1 medication being viewed by many as a potential replacement to Tir